Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Cervical Cancer Diagnostic Tests Market

4. Market Overview
4.1. Introduction
4.1.1. Diagnostic Test Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast, by Diagnostic Test
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Diagnostic Test, 2017–2031
6.3.1. Pap Smear Test
6.3.2. HPV Test
6.3.3. Colposcopy
6.3.4. Biopsy & Endocervical Curettage
6.3.5. Other diagnostic tests
6.4. Market Attractiveness Analysis, by Diagnostic Test

7. Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user

8. Global Cervical Cancer Diagnostic Tests Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region

9. North America Cervical Cancer Diagnostic Tests Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Diagnostic Test, 2017–2031
9.2.1. Pap Smear Test
9.2.2. HPV Test
9.2.3. Colposcopy
9.2.4. Biopsy & Endocervical Curettage
9.2.5. Other diagnostic tests
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Diagnostic Test
9.5.2. By End-user
9.5.3. By Country

10. Europe Cervical Cancer Diagnostic Tests Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Diagnostic Test, 2017–2031
10.2.1. Pap Smear Test
10.2.2. HPV Test
10.2.3. Colposcopy
10.2.4. Biopsy & Endocervical Curettage
10.2.5. Other diagnostic tests
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Diagnostic Test
10.5.2. By End-user
10.5.3. By Country Country/Sub-region

11. Asia Pacific Cervical Cancer Diagnostic Tests Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Diagnostic Test, 2017–2031
11.2.1. Pap Smear Test
11.2.2. HPV Test
11.2.3. Colposcopy
11.2.4. Biopsy & Endocervical Curettage
11.2.5. Other diagnostic tests
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Others
11.4. Market Value Forecast, by Country Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Diagnostic Test
11.5.2. By End-user
11.5.3. By Country Country/Sub-region

12. Latin America Cervical Cancer Diagnostic Tests Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Diagnostic Test, 2017–2031
12.2.1. Pap Smear Test
12.2.2. HPV Test
12.2.3. Colposcopy
12.2.4. Biopsy & Endocervical Curettage
12.2.5. Other diagnostic tests
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Specialty Clinics
12.3.3. Others
12.4. Market Value Forecast, by Country Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Diagnostic Test
12.5.2. By End-user
12.5.3. By Country Country/Sub-region

13. Middle East & Africa Cervical Cancer Diagnostic Tests Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Diagnostic Test, 2017–2031
13.2.1. Pap Smear Test
13.2.2. HPV Test
13.2.3. Colposcopy
13.2.4. Biopsy & Endocervical Curettage
13.2.5. Other diagnostic tests
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Specialty Clinics
13.3.3. Others
13.4. Market Value Forecast, by Country Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Diagnostic Test
13.5.2. By End-user
13.5.3. By Country Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Abbott
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. BD
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Cooper Companies, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. DYSIS Medical, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. F. Hoffmann-La Roche Ltd.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Femasys, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Guided Therapeutics, Inc.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Hologic, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. QIAGEN
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Quest Diagnostics Incorporated
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview



List of Figures

List of Figures

Figure 01: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Cervical Cancer Diagnostic Tests Market Value Share Analysis, by Diagnostic Test, 2021 and 2031

Figure 03: Global Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pap Smear Test, 2017–2031

Figure 04 Global Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by HPV Test, 2017–2031

Figure 05: Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colposcopy, 2017–2031

Figure 06: Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biopsy & Endocervical Curettage, 2017–2031

Figure 07: Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 08: Global Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022–2031

Figure 09: Global Cervical Cancer Diagnostic Tests Market Value Share Analysis, by End-user, 2021 and 2031

Figure 10: Global Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2031

Figure 11: Global Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2031

Figure 12: Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 13: Global Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022-2031

Figure 14: Global Cervical Cancer Diagnostic Tests Market Scenario, 2022-2031

Figure 15: Global Cervical Cancer Diagnostic Tests Market Value Share Analysis, by Region, 2022 and 2031

Figure 16: Global Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Region, 2022-2031

Figure 17: North America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 18: North America Cervical Cancer Diagnostic Tests Market Value Share (%), by Country, 2021 and 2031

Figure 19: North America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country, 2022–2031

Figure 20: North America Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031

Figure 21: North America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022–2031

Figure 22: North America Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2021 and 2031

Figure 23: North America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022–2031

Figure 24: Europe Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 25: Europe Cervical Cancer Diagnostic Tests Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 26: Europe Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 27: Europe Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031

Figure 28: Europe Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022–2031

Figure 29: Europe Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2021 and 2031

Figure 30: Europe Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2021–2031

Figure 31: Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 32: Asia Pacific Cervical Cancer Diagnostic Tests Market Value Share (%), by Country/Sub-region, 2017 and 2031

Figure 33: Asia Pacific Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 34: Asia Pacific Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031

Figure 35: Asia Pacific Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2021–2031

Figure 36: Asia Pacific Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2021 and 2031

Figure 37: Asia Pacific Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022–2031

Figure 38: Latin America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 39: Latin America Cervical Cancer Diagnostic Tests Market Value Share (%), by Country/Sub-region, 2021 and 2031

Figure 40: Latin America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 41: Latin America Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031

Figure 42: Latin America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022–2031

Figure 43: Latin America Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2022 and 2031

Figure 44: Latin America Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022–2031

Figure 45: Middle East & Africa Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2022–2031

Figure 46: Middle East & Africa Cervical Cancer Diagnostic Tests Market Value Share (%), by Country/Sub-region, 2022 and 2031

Figure 47: Middle East & Africa Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Country/Sub-region

Figure 48: Middle East & Africa Cervical Cancer Diagnostic Tests Market Value Share (%), by Product, 2021 and 2031

Figure 49: Middle East & Africa Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by Product, 2022–2031

Figure 50: Middle East & Africa Cervical Cancer Diagnostic Tests Market Value Share (%), by End-user, 2021 and 2031

Figure 51: Middle East & Africa Cervical Cancer Diagnostic Tests Market Attractiveness Analysis, by End-user, 2022–2031

Figure 52: Global Cervical Cancer Diagnostic Tests Market Share Analysis by Company (2021) region, 2022–2031

List of Tables

List of Table

Table 01: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn) Forecast, by Product, 2022–2031

Table 02: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn) Forecast, by End-user, 2022–2031

Table 03: Global Cervical Cancer Diagnostic Tests Market Value (US$ Mn) Forecast, by Region, 2022–2031

Table 04: North America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country, 2022–2031

Table 05: North America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022–2031

Table 06: North America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022–2031

Table 07: Europe Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 08: Europe Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022–2031

Table 09: Europe Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022–2031

Table 10: Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 11: Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022–2031

Table 12: Asia Pacific Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022–2031

Table 13: Latin America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 14: Latin America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022–2031

Table 15: Latin America Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022–2031

Table 16: Middle East & Africa Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022–2031

Table 17: Middle East & Africa Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by Product, 2022–2031

Table 18: Middle East & Africa Cervical Cancer Diagnostic Tests Market Revenue (US$ Mn) Forecast, by End-user, 2022–2031